维普中文期刊产品整合服务
256篇 您的检索式:作者名="Vlahovic"
    题名 作者 年代 出处 被引量
1重组脊髓灰质炎病毒用于治疗复发胶质母细胞瘤(英文)显示文摘Background The prognosis of patients with recurrent World Health Organization(WHO)grade IV malignant glioma is dismal,and there is currently no effective therapy.We conducted a dose-finding and toxicity study in this population of patients,evaluating convection-enhanced,intratumoral delivery of the recombinant nonpathogenic polio-rhinovirus chimera(PVSRIPO).PVSRIPO recognizes the poliovirus receptor CD155,which is widely expressed in neoplastic cells of solid tumors and in major components of the tumor microenvironment.Methods We enrolled consecutive adult patients who had recurrent supratentorial WHO grade IV malignant glioma,confirmed on histopathological testing,with measurable disease(contrast-enhancing tumor of≥1 cm and≤5.5 cm in the greatest dimension).The study evaluated seven doses,ranging between 107 and 1010 50%tissue-culture infectious doses(TCID50),first in a dose-escalation phase and then in a dose-expansion phase.Results From May 2012 through May 2017,a total of 61 patients were enrolled and received a dose of PVSRIPO.Dose level-1(5.0×107TCID50)was identified as the phase 2 dose.One dose-limiting toxic effect was observed;a patient in whom dose level 5(1010TCID50)was administered had a grade 4 intracranial hemorrhage immediately after the catheter was removed.To mitigate locoregional inflammation of the infused tumor with prolonged glucocorticoid use,dose level 5 was deescalated to reach the phase 2 dose.In the dose-expansion phase,19%of the patients had a PVSRIPO-related adverse event of grade 3 or higher.Overall survival among the patients who received PVSRIPO reached a plateau of 21%(95%confidence interval,11 to 33)at 24 months that was sustained at 36 months.Conclusions Intratumoral infusion of PVSRIPO in patients with recurrent WHO grade IV malignant glioma confirmed the absence of neurovirulent potential.The survival rate among patients who receivedPVSRIPO immunotherapy was higher at 24 and 36 months than the rate among historical controls.Desjardins A Gromeier M Herndon JE 2nd Beaubier N Bolognesi DP Friedman AH Friedman HS McSherry F Muscat AM Nair S Peters KB Randazzo D Sampson JH Vlahovic G Harrison WT McLendon RE Ashley D Bigner DD 2018中华神经外科疾病研究杂志2018,17,4:2
2Association be-tween injection practices and duration of injection among re-cently initiated injection drug users显示文摘Becker Buxton M Vlahov D Strathdee SA 2004Drug Alcohol Depend2004,75,2:1
3DNA methylation as a regulatory mechanism for gene expression in mammals显示文摘Serman A Vlahovic M Serman L 2006Coll Antropol2006,30,3:1
4Micro RNA-31 controls hair cycle-associated changes in gene expression pro- grams of the skin and hair follicle显示文摘Mardaryev A N Ahmed M I Vlahov N V 2010The FASEB Journal2010,24,10:1
5The epidemiology of post-traumatic Stress disorder after disasters 显示文摘Galea S Nandi A Vlahov D 2005Epidemiol Rev2005,27,:1
6Of mice and men: teratomas and teratocarcinomas显示文摘Bulic-Jakus F Ulamec M Vlahovic M 2006Coll Antropol2006,30,4:1
7Activation of tyrosine kinases in cancer显示文摘Vlahovic G Crawford J 2003Oncologist2003,8,6:1
8Oxidative stress parameters as possible urine markers in patients with diabetic nephropathy 显示文摘Cvetkovic T Mitic B Lazarevic G Vlahovic P Antic S Stefanovic V 2009J Diabetes Complications2009,23,:1
9The effect of piracetam on the local cortical cerebral blood flow in cats显示文摘Vlahov V Nikolova M Nikolov R 1980Arch Int Pharmacodyn1980,243,:1
10Synthesis and biological evaluation of EC20:a new folate-derived,^99mTc-based radiopharmaceutical显示文摘Leamon CP Parker MA Vlahov IR 2002Bioconjug Chem2002,13,6:1
11Urbanization, urbanicity, and health显示文摘David Vlahov Sandro Galea 2002Journal of Urban Health2002,,1:1
12Attitudes Toward Hrq Treatments Influence Unsafe Sexual and Injection Practices among Injecting Drug Users 显示文摘Tun W Celentano DD Vlahov D 2003AIDS2003,17,13:1
13Significance of opening the medullar canal in surgical treatment of simple bone cyst显示文摘Bumci I Vlahovic T 2002J Pediatr Orthop2002,22,:1
14Synthesis and biological evaluation of EC140:a no- vel folate-targeted vinca alkaloid conjugate 显示文摘LEAMON C P REDDY J A VLAHOV I R 2006Bio- conjug Chem2006,17,5:1
15A new synthesis of roxatidine acetate 显示文摘Tarpanob V Vlahov R Penkov M 1999SyntheticCommunications1999,29,1:1
16Evaluation of disulfide reduction during receptor-mediated endocytosis by using FRET imaging显示文摘Yang J Chen H Vlahov I R 2006Proc Natl Acad Sci USA2006,103,13:1
17Correlates of enrollment in methadone maintenance treatment programs differ by HIVserostatus显示文摘Shah NG Celentano DD Vlahov D 2000AIDS2000,14,13:1
18Urban health:evidence,challenge,and directions显示文摘Galea S Vlahov D 0,,:1
19Adjunctive effect of hyperbaric oxygen treatment after thrombolysis on left ventricular function in patients with acute myocardial infarction显示文摘Dekleva M Neskovic A Vlahovic A 0,,:1
20Re- gioselective synthesis of folate receptor-targeted agents derived from epothilone analogs and folic acid 显示文摘VLAHOV I R VITE G D KLEINDL P J 2010Bioorg Med Chem Lett2010,20,15:1
返回顶部 每页显示:
共13页 首页 上一页 第1页 下一页 末页 /13 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费